drugset / Trial / NCT00908128
Mycophenolate Mofetil Tablets Under Fed Conditions
RandomizedCrossoverOpen-labelOther
Summary
The objective of this study was to evaluate the comparative bioavailability between Mycophenolate Mofetil 500 mg Tablets (test) and CellCept® 500 mg Tablets (reference), after a single-dose in healthy subjects under fed conditions.
Timeline
- Start
- 2006-08
- Primary completion
- 2006-08
- Completion
- 2006-08
Outcome
Met primary endpoint
registry Geometric Test/Ref Ratio x 100 90.96 (90% CI 82.40 to 100.41) NCT00908128 ↗
registry Geometric Test/Ref Ratio x 100 99.16 (90% CI 96.24 to 102.16) NCT00908128 ↗
registry Geometric Test/Ref Ratio x 100 98.78 (90% CI 95.76 to 101.89) NCT00908128 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mycophenolate Mofetil | Small molecule | 500 mg | — |
Indications
No indication recorded.